Indications: Upadacitinib is a Janus kinase (JAK) inhibitor indicated for the treatment of adults with moderate to severe active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate.
Your purchase will delivered in 1 shipment
Your shopping bag is empty. Start shopping now.